Testing to pinpoint diagnoses
Unique testing for greater accuracy
Due to the growing prevalence of autoimmune neurological conditions in kids, we offer a comprehensive autoimmune evaluation — the only one of its kind. It’s more efficient and cost-effective than ordering individual antibody tests, while covering a greater spectrum of conditions. We also partner with Mayo Clinic’s world-renowned biochemical genetics laboratory for the most sophisticated technology and processes available for pediatric neurogenetic testing. You’ll have access to top pediatric neurologists, neurogeneticists, and genetic counselors who offer guidance and expertise for a better pediatric patient experience.
CNS demyelinating disease
Hereditary hearing loss
We use advanced technologies, tests, and methodologies to give you the most accurate results possible for your pediatric patients. This includes using digital droplet pulmonary chain reaction (ddPCR) to test for genetic hearing loss. Our technology is more reliable than all other genetic hearing loss tests used by other reference labs.
To minimize the risk of human error in test result interpretation, we utilize technologies and develop unique tests that deliver unambiguous results. For instance, we use kappa free light technology to accurately test for multiple sclerosis (MS) in children. The standard MS test leaves room for human misinterpretation, while ours uses a mechanical process that gives a clear diagnostic result.
Demystifying the once unknown
One of the great challenges in interpreting genetic test results is understanding the role that variants of unknown significance may play in a child's diagnosis. But our technology and expertise changes this. Your care team will receive a detailed report that categorizes variants of unknown significance within the test result, so you can accurately pinpoint diagnosis.
Maria Alice Willrich, Ph.D., explains kappa free light chain testing — Mayo Clinic Laboratories' data-driven approach to diagnose multiple sclerosis. The automated assay is more sensitive, cost-effective, and faster than traditional oligoclonal banding, enabling definitive answers for the challenging diagnosis.
Developed with input from clinical specialists, the AudioloGene Hereditary Hearing Loss Panel offers the most comprehensive genetic assessment for hearing loss available today.
This “Specialty Testing” webinar will address the clinical presentations, evaluation (including diagnostic antibody testing), and treatment of autoimmune pediatric CNS disorders, including encephalitides and myelopathies.
Autoimmune encephalitis and myelitis is increasingly recognized as a cause of CNS disease in children and teens. Andrew McKeon, M.B., B.Ch., M.D, gives an overview of this test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken due to the results of this testing.